Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EPILEPSY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
EPILEPSY is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, therapeutic target. Associated with ALS, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS. Connected to 508 entities in the SciDEX knowledge graph.
| Gene Symbol | EPILEPSY |
| Full Name | Hippocampal CA3 Pyramidal Neurons in Epilepsy |
| Aliases | Seizure disorder, Epileptic syndrome |
| Protein Type | Cell Type |
| Associated Diseases | ALS, Aging, Alzheimer, Alzheimer Disease, Alzheimer'S Disease |
| Interactions | ALZHEIMER'S DISEASE, AMYLOID, ALZHEIMER, NEUROINFLAMMATION, MICROGLIA, ERBB4 |
| KG Connections | 1552 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
EPILEPSY(["EPILEPSY"])
Epilepsy["Epilepsy"]
Als["Als"]
Inflammation["Inflammation"]
Neurodegeneration["Neurodegeneration"]
ALZHEIMER_S_DISEASE(["ALZHEIMER'S DISEASE"])
ALZHEIMER(["ALZHEIMER"])
Mtor["Mtor"]
MTOR(["MTOR"])
Alzheimer["Alzheimer"]
Parkinson["Parkinson"]
Neuroinflammation["Neuroinflammation"]
EPILEPSY -->|"associated with"| Epilepsy
EPILEPSY -->|"therapeutic target"| Als
EPILEPSY -->|"therapeutic target"| Epilepsy
EPILEPSY -->|"activates"| Inflammation
EPILEPSY -->|"activates"| Als
EPILEPSY -->|"activates"| Neurodegeneration
EPILEPSY -->|"associated with"| ALZHEIMER_S_DISEASE
EPILEPSY -->|"associated with"| ALZHEIMER
EPILEPSY -->|"therapeutic target"| Mtor
EPILEPSY -->|"therapeutic target"| MTOR
ALZHEIMER_S_DISEASE -->|"associated with"| EPILEPSY
EPILEPSY -->|"associated with"| Alzheimer
EPILEPSY -->|"causes"| Epilepsy
EPILEPSY -->|"associated with"| Parkinson
EPILEPSY -->|"activates"| Neuroinflammation
style EPILEPSY fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Epilepsy | associated_with | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Epilepsy | therapeutic_target | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| Alzheimer | associated_with | disease | 0.95 |
| Alzheimer | associated_with | disease | 0.95 |
| Epilepsy | causes | disease | 0.95 |
| Parkinson | associated_with | disease | 0.95 |
| Neuroinflammation | activates | disease | 0.95 |
| Neurodegeneration | activates | disease | 0.95 |
| Alzheimer | therapeutic_target | disease | 0.95 |
| Sudden Unexpected Death in Epilepsy | contributes_to | disease | 0.95 |
| temporal lobe | affects | brain_region | 0.90 |
| neurons | affects | cell_type | 0.90 |
| hippocampus | affects | brain_region | 0.90 |
| cortex | affects | brain_region | 0.90 |
| astrocytes | affects | cell_type | 0.90 |
| microglia | affects | cell_type | 0.90 |
| oxidative stress response | involves | pathway | 0.90 |
| neural stem cells | affects | cell_type | 0.90 |
| Oxidative Stress | therapeutic_target | pathway | 0.90 |
| PARKINSON | associated_with | gene | 0.90 |
| ASTROCYTE | activates | gene | 0.90 |
| ALZHEIMER | therapeutic_target | gene | 0.90 |
| Als | associated_with | disease | 0.85 |
| Parkinson | associated_with | disease | 0.85 |
| Epilepsy | contributes_to | disease | 0.85 |
| Epilepsy | regulates | disease | 0.85 |
| Inflammation | therapeutic_target | disease | 0.85 |
| Neuroinflammation | therapeutic_target | disease | 0.85 |
| Neuroinflammation | activates | disease | 0.85 |
| Parkinson | therapeutic_target | disease | 0.85 |
| Alzheimer | therapeutic_target | disease | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Neurodegeneration | therapeutic_target | disease | 0.85 |
| glutamate signaling | involves | pathway | 0.80 |
| glutamate receptor | involves | receptor | 0.80 |
| PI3K-AKT-mTOR signaling | involves | pathway | 0.80 |
| pyroptosis | involves | pathway | 0.80 |
| neuron excitement | causes | biological_process | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MTOR | therapeutic_target | gene | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| EPILEPSY | associated_with | gene | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| EPILEPSY | therapeutic_target | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 0.98 |
| ASTROCYTES | activates | gene | 0.95 |
| APOPTOSIS | activates | gene | 0.95 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.95 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.95 |
| NEURODEGENERATION | therapeutic_target | gene | 0.95 |
| ALZHEIMER | associated_with | gene | 0.95 |
| EPILEPSY | causes | gene | 0.95 |
| PARKINSON | associated_with | gene | 0.95 |
| ASTROCYTE | activates | gene | 0.95 |
| ALZHEIMER | therapeutic_target | gene | 0.95 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.95 |
| Tuberous Sclerosis Complex | causes | disease | 0.95 |
| CORTEX | interacts_with | brain_region | 0.95 |
| Antiseizure Medications | treats | drug | 0.95 |
| GABRA1 | causes | gene | 0.95 |
| GABRG2 | causes | gene | 0.95 |
| MICROGLIA | implicated_in | cell_type | 0.95 |
| everolimus | treats | drug | 0.90 |
| Ih Current | associated_with | mechanism | 0.90 |
| MTOR | involved_in | gene | 0.90 |
| Neuroinflammation | involved_in | process | 0.90 |
| Glioblastoma Multiforme | causes | disease | 0.90 |
| AUTOPHAGY GENE MUTATIONS | causes | gene | 0.90 |
| HCN1 MUTATIONS | causes | gene | 0.90 |
| Inhibitory Synapse Elimination | contributes_to | process | 0.90 |
| Glioblastoma Multiforme | associated_with | disease | 0.90 |
| Autophagy | associated_with | pathway | 0.90 |
| ASTROCYTES | associated_with | cell_type | 0.90 |
| M305L | risk_factor_for | biomarker | 0.90 |
| D401H | risk_factor_for | biomarker | 0.90 |
| RLN1 | associated_with | protein | 0.90 |
| HMGB1 | biomarker_for | protein | 0.90 |
| Neuroinflammatory Pathways | involved_in | pathway | 0.90 |
| NEUROINFLAMMATION | therapeutic_target | gene | 0.85 |
| PARKINSON'S DISEASE | associated_with | gene | 0.85 |
| MICROGLIA | activates | gene | 0.85 |
| EPILEPSY | contributes_to | gene | 0.85 |
| AUTOPHAGY | activates | gene | 0.85 |
| EPILEPSY | regulates | gene | 0.85 |
| Propofol | treats | drug | 0.85 |
| HCN1 Epilepsy Mutants | risk_factor_for | biomarker | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
synaptic biology | 2026-04-14 | 1 hypotheses Top: 0.526
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||